{
  "source": "Nasdaq Nordic Company News",
  "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
  "status": "retrieved",
  "company": "EQL Pharma",
  "reports": [
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:28:16Z",
      "company": "EQL Pharma AB",
      "title": "EQL Pharma Årsredovisning 2025/2026",
      "category": "Bokslut och Verksamhetsberättelse",
      "date": "2026-07-24",
      "language": "sv",
      "report_type": "annual-report",
      "fiscal_year": 2026,
      "quarter": "annual",
      "period": "2026-annual",
      "report_key": "2026:annual",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=bce76992aa38bcf12986ce27193ba94fa&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-annual\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-annual\\release.txt",
      "attachments": [
        {
          "label": "07231483.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a76a4c5117e3991ffc7424168f48001fe",
          "final_url": "https://attachment.news.eu.nasdaq.com/a76a4c5117e3991ffc7424168f48001fe",
          "filename": "07231483.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-annual\\07231483.pdf",
          "content_type": "application/pdf",
          "size": 11876836,
          "sha256": "703dc9cf331cb86c3e871eef359c8c9e1f350bd66693297339ebc43f54cfbb50",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-annual\\07231483.pdf",
            "filename": "07231483.pdf",
            "extension": ".pdf",
            "size": 11876836,
            "sha256": "703dc9cf331cb86c3e871eef359c8c9e1f350bd66693297339ebc43f54cfbb50",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-annual\\extracted\\07231483\\07231483.txt",
            "text_chars": 270184,
            "metadata": {
              "page_count": 94,
              "empty_pages": 0,
              "encrypted": true
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-annual\\extracted\\07231483\\07231483.extraction.json"
          }
        }
      ],
      "announcement_id": "1455529",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:28:18Z",
      "company": "EQL Pharma AB",
      "title": "Bokslutskommuniké april 2025 - mars 2026",
      "category": "Bokslutskommuniké",
      "date": "2026-05-08",
      "language": "sv",
      "report_type": "year-end-report",
      "fiscal_year": 2025,
      "quarter": "q4",
      "period": "2025-q4",
      "report_key": "2025:q4",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b373d1ef2ff828bdf3c827517620fca18&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q4\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q4\\release.txt",
      "attachments": [
        {
          "label": "05070091.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a6e7ef5729043f29a241ad7d874d6e332",
          "final_url": "https://attachment.news.eu.nasdaq.com/a6e7ef5729043f29a241ad7d874d6e332",
          "filename": "05070091.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q4\\05070091.pdf",
          "content_type": "application/pdf",
          "size": 613524,
          "sha256": "243bec63f15471136e369b234f362772ed692471915062c0de56f5f1daf47455",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q4\\05070091.pdf",
            "filename": "05070091.pdf",
            "extension": ".pdf",
            "size": 613524,
            "sha256": "243bec63f15471136e369b234f362772ed692471915062c0de56f5f1daf47455",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q4\\extracted\\05070091\\05070091.txt",
            "text_chars": 41933,
            "metadata": {
              "page_count": 21,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q4\\extracted\\05070091\\05070091.extraction.json"
          }
        }
      ],
      "announcement_id": "1440834",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:28:22Z",
      "company": "EQL Pharma AB",
      "title": "Delårsrapport April - december 2025",
      "category": "Interimsrapport",
      "date": "2026-02-03",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2026,
      "quarter": "q1",
      "period": "2026-q1",
      "report_key": "2026:q1",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=bbe946ee124582ac108ed3da98d82996c&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-q1\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-q1\\release.txt",
      "attachments": [
        {
          "label": "02035276.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a951a3c44992327bb2db77496fad2b858",
          "final_url": "https://attachment.news.eu.nasdaq.com/a951a3c44992327bb2db77496fad2b858",
          "filename": "02035276.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-q1\\02035276.pdf",
          "content_type": "application/pdf",
          "size": 1153425,
          "sha256": "52422a673f021a36691639ade9117fa61ea8a8a88ba33670de0bfd53b34b609c",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-q1\\02035276.pdf",
            "filename": "02035276.pdf",
            "extension": ".pdf",
            "size": 1153425,
            "sha256": "52422a673f021a36691639ade9117fa61ea8a8a88ba33670de0bfd53b34b609c",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-q1\\extracted\\02035276\\02035276.txt",
            "text_chars": 42371,
            "metadata": {
              "page_count": 21,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2026-q1\\extracted\\02035276\\02035276.extraction.json"
          }
        }
      ],
      "announcement_id": "1417406",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:28:28Z",
      "company": "EQL Pharma AB",
      "title": "Halvårsrapport April - september 2025",
      "category": "Halvårsrapport",
      "date": "2025-11-05",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2025,
      "quarter": "q2",
      "period": "2025-q2",
      "report_key": "2025:q2",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b551840162d2f2fb02f90ddfb404de32d&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q2\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q2\\release.txt",
      "attachments": [
        {
          "label": "11044974.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a4170b2c5e7518f33330fe90c4bf9e7a3",
          "final_url": "https://attachment.news.eu.nasdaq.com/a4170b2c5e7518f33330fe90c4bf9e7a3",
          "filename": "11044974.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q2\\11044974.pdf",
          "content_type": "application/pdf",
          "size": 1730239,
          "sha256": "a03a4624f6bc622347d76c62bd8885b999eb9fe1f5ddf3b6f0ad7fcee82b230b",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q2\\11044974.pdf",
            "filename": "11044974.pdf",
            "extension": ".pdf",
            "size": 1730239,
            "sha256": "a03a4624f6bc622347d76c62bd8885b999eb9fe1f5ddf3b6f0ad7fcee82b230b",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q2\\extracted\\11044974\\11044974.txt",
            "text_chars": 48714,
            "metadata": {
              "page_count": 22,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q2\\extracted\\11044974\\11044974.extraction.json"
          }
        }
      ],
      "announcement_id": "1398679",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:28:34Z",
      "company": "EQL Pharma AB",
      "title": "Interim Report April - June 2025",
      "category": "Interim report (Q1 and Q3)",
      "date": "2025-08-08",
      "language": "en",
      "report_type": "interim-report",
      "fiscal_year": 2025,
      "quarter": "q3",
      "period": "2025-q3",
      "report_key": "2025:q3",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b84fd29d70f23162925698c018f18538f&lang=en&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q3\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q3\\release.txt",
      "attachments": [
        {
          "label": "08078305.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/ab1555ee131c9a3524768cebab0234307",
          "final_url": "https://attachment.news.eu.nasdaq.com/ab1555ee131c9a3524768cebab0234307",
          "filename": "08078305.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q3\\08078305.pdf",
          "content_type": "application/pdf",
          "size": 1325247,
          "sha256": "e9144e3fb9d5c88ba59507b120d14abfad58884f283d9a57b055484a0b3abb39",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q3\\08078305.pdf",
            "filename": "08078305.pdf",
            "extension": ".pdf",
            "size": 1325247,
            "sha256": "e9144e3fb9d5c88ba59507b120d14abfad58884f283d9a57b055484a0b3abb39",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q3\\extracted\\08078305\\08078305.txt",
            "text_chars": 40050,
            "metadata": {
              "page_count": 22,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q3\\extracted\\08078305\\08078305.extraction.json"
          }
        }
      ],
      "announcement_id": "1382395",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:28:54Z",
      "company": "EQL Pharma AB",
      "title": "EQL Pharma Årsredovisning 2024/2025",
      "category": "Bokslut och Verksamhetsberättelse",
      "date": "2025-07-25",
      "language": "sv",
      "report_type": "annual-report",
      "fiscal_year": 2025,
      "quarter": "annual",
      "period": "2025-annual",
      "report_key": "2025:annual",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=bd91c525727fc0df0295d99befb524417&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-annual\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-annual\\release.txt",
      "attachments": [
        {
          "label": "07243617.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a69387fbe38be4ed925cc34eb4f8b431e",
          "final_url": "https://attachment.news.eu.nasdaq.com/a69387fbe38be4ed925cc34eb4f8b431e",
          "filename": "07243617.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-annual\\07243617.pdf",
          "content_type": "application/pdf",
          "size": 11938251,
          "sha256": "2041a192e045b1c51e308ed275f077ecb0a7b85b817d27175b61061e16060ea7",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-annual\\07243617.pdf",
            "filename": "07243617.pdf",
            "extension": ".pdf",
            "size": 11938251,
            "sha256": "2041a192e045b1c51e308ed275f077ecb0a7b85b817d27175b61061e16060ea7",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-annual\\extracted\\07243617\\07243617.txt",
            "text_chars": 268324,
            "metadata": {
              "page_count": 95,
              "empty_pages": 0,
              "encrypted": true
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-annual\\extracted\\07243617\\07243617.extraction.json"
          }
        }
      ],
      "announcement_id": "1380768",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:28:57Z",
      "company": "EQL Pharma AB",
      "title": "Bokslutskommuniké April 2024 - Mars 2025",
      "category": "Bokslutskommuniké",
      "date": "2025-05-08",
      "language": "sv",
      "report_type": "year-end-report",
      "fiscal_year": 2024,
      "quarter": "q4",
      "period": "2024-q4",
      "report_key": "2024:q4",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b33f1714716c3ecac1a2d196442217fac&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q4\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q4\\release.txt",
      "attachments": [
        {
          "label": "05078976.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a1c2d5614926c2f3a4b7a6449e356924e",
          "final_url": "https://attachment.news.eu.nasdaq.com/a1c2d5614926c2f3a4b7a6449e356924e",
          "filename": "05078976.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q4\\05078976.pdf",
          "content_type": "application/pdf",
          "size": 1358908,
          "sha256": "5064cd8e9d54e23a20f7172bb0eb219d00f48d953223dc8841a4d9df4e5f873f",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q4\\05078976.pdf",
            "filename": "05078976.pdf",
            "extension": ".pdf",
            "size": 1358908,
            "sha256": "5064cd8e9d54e23a20f7172bb0eb219d00f48d953223dc8841a4d9df4e5f873f",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q4\\extracted\\05078976\\05078976.txt",
            "text_chars": 45447,
            "metadata": {
              "page_count": 23,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q4\\extracted\\05078976\\05078976.extraction.json"
          }
        }
      ],
      "announcement_id": "1361695",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:29:02Z",
      "company": "EQL Pharma AB",
      "title": "Delårsrapport April - december 2024",
      "category": "Interimsrapport",
      "date": "2025-02-05",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2025,
      "quarter": "q1",
      "period": "2025-q1",
      "report_key": "2025:q1",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b189d065478acd84326e7dd4525a4b538&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q1\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q1\\release.txt",
      "attachments": [
        {
          "label": "02041667.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/aa2d7acdd1c8ac2d3da6749e231f2364f",
          "final_url": "https://attachment.news.eu.nasdaq.com/aa2d7acdd1c8ac2d3da6749e231f2364f",
          "filename": "02041667.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q1\\02041667.pdf",
          "content_type": "application/pdf",
          "size": 1372849,
          "sha256": "e9b7efd792d9f911a366e1328b400f5c7fa42b22ba5d5849f8b6f2af1d93d358",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q1\\02041667.pdf",
            "filename": "02041667.pdf",
            "extension": ".pdf",
            "size": 1372849,
            "sha256": "e9b7efd792d9f911a366e1328b400f5c7fa42b22ba5d5849f8b6f2af1d93d358",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q1\\extracted\\02041667\\02041667.txt",
            "text_chars": 42822,
            "metadata": {
              "page_count": 22,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2025-q1\\extracted\\02041667\\02041667.extraction.json"
          }
        }
      ],
      "announcement_id": "1340759",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:29:08Z",
      "company": "EQL Pharma AB",
      "title": "Halvårsrapport april - september 2024",
      "category": "Halvårsrapport",
      "date": "2024-11-06",
      "language": "sv",
      "report_type": "interim-report",
      "fiscal_year": 2024,
      "quarter": "q2",
      "period": "2024-q2",
      "report_key": "2024:q2",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=ba6acb8a9725523ec3eead0bd810d0fae&lang=sv&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q2\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q2\\release.txt",
      "attachments": [
        {
          "label": "11052871.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a491e4fc30d35b04dbb16ea9d2080b8a4",
          "final_url": "https://attachment.news.eu.nasdaq.com/a491e4fc30d35b04dbb16ea9d2080b8a4",
          "filename": "11052871.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q2\\11052871.pdf",
          "content_type": "application/pdf",
          "size": 1278665,
          "sha256": "d3a67c0326bd38a098dbc62a0ecab4df948b6a6769b3c8efa922fe6aab299fc5",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q2\\11052871.pdf",
            "filename": "11052871.pdf",
            "extension": ".pdf",
            "size": 1278665,
            "sha256": "d3a67c0326bd38a098dbc62a0ecab4df948b6a6769b3c8efa922fe6aab299fc5",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q2\\extracted\\11052871\\11052871.txt",
            "text_chars": 43765,
            "metadata": {
              "page_count": 23,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q2\\extracted\\11052871\\11052871.extraction.json"
          }
        }
      ],
      "announcement_id": "1325947",
      "status": "retrieved"
    },
    {
      "source": "Nasdaq Nordic",
      "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2",
      "retrieved_at": "2026-08-07T03:29:13Z",
      "company": "EQL Pharma AB",
      "title": "Interim Report April - June 2024",
      "category": "Interim report (Q1 and Q3)",
      "date": "2024-08-08",
      "language": "en",
      "report_type": "interim-report",
      "fiscal_year": 2024,
      "quarter": "q3",
      "period": "2024-q3",
      "report_key": "2024:q3",
      "release_url": "https://view.news.eu.nasdaq.com/view?id=b00bc27f31921715c1f87439b8ab2c90f&lang=en&src=listed",
      "release_html_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q3\\release.html",
      "release_text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q3\\release.txt",
      "attachments": [
        {
          "label": "08072800.pdf",
          "url": "https://attachment.news.eu.nasdaq.com/a0a466069e69b7389d170f4dbd2a6c050",
          "final_url": "https://attachment.news.eu.nasdaq.com/a0a466069e69b7389d170f4dbd2a6c050",
          "filename": "08072800.pdf",
          "local_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q3\\08072800.pdf",
          "content_type": "application/pdf",
          "size": 1579760,
          "sha256": "088da055ed4b7355274205a6d0bbae3314c35955cc4561f42f7607f4e3e34b0e",
          "extraction": {
            "source_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q3\\08072800.pdf",
            "filename": "08072800.pdf",
            "extension": ".pdf",
            "size": 1579760,
            "sha256": "088da055ed4b7355274205a6d0bbae3314c35955cc4561f42f7607f4e3e34b0e",
            "status": "extracted",
            "text_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q3\\extracted\\08072800\\08072800.txt",
            "text_chars": 37269,
            "metadata": {
              "page_count": 22,
              "empty_pages": 0,
              "encrypted": false
            },
            "children": [],
            "warnings": [],
            "manifest_path": "D:\\Web\\aktieanalys\\data\\eql-pharma\\nasdaq-reports\\reports\\2024-q3\\extracted\\08072800\\08072800.extraction.json"
          }
        }
      ],
      "announcement_id": "1309778",
      "status": "retrieved"
    }
  ],
  "attempts": [
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 61,
      "new_rows": 61,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "09aced038f7e5771ea239c02173e64210e638f03c2cf71108b3e0bca3a523598"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=61&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 61,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "2e0978ce61952f270149e9b0f07af6f1a36e998b27724ffc89de8392d6775758"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 15,
      "new_rows": 15,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "377f7e3d8909d327502dfbfedc1374c50bbaa1829a5a77e17a8df50b8beaa866"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=15&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 15,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "11f6a638635089d9cd0aa6b3cd9b352af0e40b705e883c53c935beaa1b8bf549"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 60,
      "new_rows": 60,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "e12ab566dff097a924ae3ee232c2d93b9e7eb16eab550f66102001206ced73b5"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=60&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 60,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "a1f8de1ba9a608e16269bc192e114dd3c9be1439428251de15dbbca2eceb16dc"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 5,
      "new_rows": 5,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "182ed21b06c4b4684a4def0116ca641a8d29c3b1ecdb9ef0c261c2e4b4ef59fe"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=5&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 5,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2023-01-01",
      "to_date": "",
      "cache_tag": "broad",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "d97ee824ab5793095b25a383238d191f6e98476d65197a4c886f360e00a0680f"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 61,
      "new_rows": 61,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "09aced038f7e5771ea239c02173e64210e638f03c2cf71108b3e0bca3a523598",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=61&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 61,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "2e0978ce61952f270149e9b0f07af6f1a36e998b27724ffc89de8392d6775758",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 15,
      "new_rows": 15,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "377f7e3d8909d327502dfbfedc1374c50bbaa1829a5a77e17a8df50b8beaa866",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=15&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 15,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "11f6a638635089d9cd0aa6b3cd9b352af0e40b705e883c53c935beaa1b8bf549",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 76,
      "new_rows": 76,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "7af18f590d4186e033a85ef496f5e1acfde3d9bd31250c9a1b5969b93b4f2184",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=76&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 76,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "053091224aa65663a328edefad16d1914ea2d96cf180d0b6bb10fb32b3d58cfc",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 60,
      "new_rows": 60,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "e12ab566dff097a924ae3ee232c2d93b9e7eb16eab550f66102001206ced73b5",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=60&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 60,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "a1f8de1ba9a608e16269bc192e114dd3c9be1439428251de15dbbca2eceb16dc",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 5,
      "new_rows": 5,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "182ed21b06c4b4684a4def0116ca641a8d29c3b1ecdb9ef0c261c2e4b4ef59fe",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=5&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 5,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "d97ee824ab5793095b25a383238d191f6e98476d65197a4c886f360e00a0680f",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 65,
      "new_rows": 65,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "542c1ac645c3980301a48aac8dca67a2112ede673a8adaf3b6fa95d51f5e7dd9",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=65&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 65,
      "pagination": "row-offset",
      "query_text": "EQL Pharma",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "2cb773d496282c07294c906fab8678229fe72de3a78c27092a5b06fec7a71492",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 61,
      "new_rows": 61,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "09aced038f7e5771ea239c02173e64210e638f03c2cf71108b3e0bca3a523598",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=61&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 61,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "2e0978ce61952f270149e9b0f07af6f1a36e998b27724ffc89de8392d6775758",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 15,
      "new_rows": 15,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "377f7e3d8909d327502dfbfedc1374c50bbaa1829a5a77e17a8df50b8beaa866",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=15&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 15,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "11f6a638635089d9cd0aa6b3cd9b352af0e40b705e883c53c935beaa1b8bf549",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 76,
      "new_rows": 76,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "7af18f590d4186e033a85ef496f5e1acfde3d9bd31250c9a1b5969b93b4f2184",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=76&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 76,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "053091224aa65663a328edefad16d1914ea2d96cf180d0b6bb10fb32b3d58cfc",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 60,
      "new_rows": 60,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "e12ab566dff097a924ae3ee232c2d93b9e7eb16eab550f66102001206ced73b5",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=60&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 60,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "a1f8de1ba9a608e16269bc192e114dd3c9be1439428251de15dbbca2eceb16dc",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 5,
      "new_rows": 5,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "182ed21b06c4b4684a4def0116ca641a8d29c3b1ecdb9ef0c261c2e4b4ef59fe",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=5&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 5,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "d97ee824ab5793095b25a383238d191f6e98476d65197a4c886f360e00a0680f",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 65,
      "new_rows": 65,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "542c1ac645c3980301a48aac8dca67a2112ede673a8adaf3b6fa95d51f5e7dd9",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=EQL+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=65&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 65,
      "pagination": "row-offset",
      "query_text": "EQL Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "2cb773d496282c07294c906fab8678229fe72de3a78c27092a5b06fec7a71492",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f5c8bedd1257bce3d40b895a576e3ae329d320655a88f2abde9296a7a9e60889",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "243a26e2ac0739a77fd5c0361406a3e08edabd9417f8b2ed54b16e66aa6c014f",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "224a221f94c154ee1e7496ce4e09cd3ec4f3ce3463fe6c9bda76e66611ca6c3a",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "243a26e2ac0739a77fd5c0361406a3e08edabd9417f8b2ed54b16e66aa6c014f",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "224a221f94c154ee1e7496ce4e09cd3ec4f3ce3463fe6c9bda76e66611ca6c3a",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 1,
      "new_rows": 1,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f7f7fac30cf3c424c121b7b2f9bc36a03d93ddfa1aabbf55c6bbb2b3d8a12fad",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=1&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 1,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "b0baeec2e2e08d034f3e6378faf59c9d544cb3d1cd4e64d2dae5360d27808f71",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "652e20e840e015551f86d04a3b3ee8b4e79eb1b34e4c15e540bde76d36ad487e",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 35,
      "new_rows": 35,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "c5b6bb30fc9fb491c48f443b6135763cb2bd65dc97af1530e43bd77d5a0ad2e8",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f911986904e742f651a2a3414defcd0f7c8f4013fa5ff4f0d87d4ef32f740e1d",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Iconovo+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Iconovo AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 36,
      "new_rows": 36,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "ac13f7efac0a8862d3cdfd4760c2b617e24f47a2dc054a52c3a2d2814d8cc36e",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 66,
      "new_rows": 66,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "9b4e8db911b9de44189ed562624165afca0d63bd79742fb2b8310ea278fca54f",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=66&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 66,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "05ce696f6b5d815a1be60dcd50e932a61ac447de308e5f857fb173294fa6680c",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "18a01642c3111275a98b8a7b0ed33e1461d2ab3720a6b85882db2a3388695b04",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 50,
      "new_rows": 50,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "29a71fd22d1e0dbd626512c4dd21a136871dd95c583d0c6e72d53cb299c923c2",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "bcfd393bbea776343c60d3766046f70ba113b34e1aeb38e488041d7f1a6d409b",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "c8dc5d27421e389c3dc8fc16ddf7c5f73756f0b948c8e3b0773d6a4034b46481",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 60,
      "new_rows": 60,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "55d508f3f021a7e1767a5954dcfd1c430777b4b14d73602b79040d0c86c88b3c",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=60&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 60,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "a1f8de1ba9a608e16269bc192e114dd3c9be1439428251de15dbbca2eceb16dc",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "c92f38788bf7ed74e6bb06366ec282ec14196973ad03bd6f8dcdad6c0b294aa8",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 15,
      "new_rows": 15,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "21329fb8575d94afdc677293d0f97dd02ccedb6ad6e33c47228bdf31f9a93b3e",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "6c16cc85bbca9099af6fbd60e068180953c8e12dbd8b6a687882893da2b5af9f",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=OssDsign+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "OssDsign AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 75,
      "new_rows": 75,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "d4fef2a395578d0607ae774d49dd3ef0ccc9cde6da6be7082cc0bdee352c04c1",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f5c8bedd1257bce3d40b895a576e3ae329d320655a88f2abde9296a7a9e60889",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 71,
      "new_rows": 71,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "6517adcb9c33fb4851ff27161ed50e36c64d48a45c86cc23eae13de4ee571d33",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=71&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 71,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "ca130a7defbb7f6f12d5f63dd8dd280da58faec173f2a8cc1162305e05303956",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 71,
      "new_rows": 71,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "6517adcb9c33fb4851ff27161ed50e36c64d48a45c86cc23eae13de4ee571d33",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=71&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 71,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "ca130a7defbb7f6f12d5f63dd8dd280da58faec173f2a8cc1162305e05303956",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f5c8bedd1257bce3d40b895a576e3ae329d320655a88f2abde9296a7a9e60889",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 53,
      "new_rows": 53,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "2fc790cfe38c3f6d43db8b02817f41ed9be98e43b4ea2f1d3328ecdf67e1782b",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=53&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 53,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "97b70c3dfc91f81834132d3ee80cbcaf3ff2271bd1df8530e6e7add78423cefb",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 53,
      "new_rows": 53,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "2fc790cfe38c3f6d43db8b02817f41ed9be98e43b4ea2f1d3328ecdf67e1782b",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Diagonal+Bio+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=53&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 53,
      "pagination": "row-offset",
      "query_text": "Diagonal Bio AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "97b70c3dfc91f81834132d3ee80cbcaf3ff2271bd1df8530e6e7add78423cefb",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f5c8bedd1257bce3d40b895a576e3ae329d320655a88f2abde9296a7a9e60889",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "7265625ed12c26a856f23a5afdeb24389d5ba156652fb5fe2fa83c41df030151",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "c7815c350fd0a12d2414198b57367771eff4b54a12b0df2e855b0077c9337381",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "7265625ed12c26a856f23a5afdeb24389d5ba156652fb5fe2fa83c41df030151",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "c7815c350fd0a12d2414198b57367771eff4b54a12b0df2e855b0077c9337381",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f5c8bedd1257bce3d40b895a576e3ae329d320655a88f2abde9296a7a9e60889",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 3,
      "new_rows": 3,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "5f2f36c289d4fee090ec422f405170ba8b57eb66e152f55ec803c16b6d462b8d",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=3&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 3,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "449de37c3458e07fa7a04e480e0ef1298d825283b8c7f36964108a8672015b9a",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 3,
      "new_rows": 3,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "5f2f36c289d4fee090ec422f405170ba8b57eb66e152f55ec803c16b6d462b8d",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Gasporox+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=3&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 3,
      "pagination": "row-offset",
      "query_text": "Gasporox AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "449de37c3458e07fa7a04e480e0ef1298d825283b8c7f36964108a8672015b9a",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f5c8bedd1257bce3d40b895a576e3ae329d320655a88f2abde9296a7a9e60889",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "6f2e034a9b9fbe296a1621c817c1b1636ada6ecf91a41a5991be425dec60f22f",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 52,
      "new_rows": 52,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "9dc62280e03d60b9b60c54407d8d5048ca703f4f9cb702f3938ac7d97d19aa09",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "6f2e034a9b9fbe296a1621c817c1b1636ada6ecf91a41a5991be425dec60f22f",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 52,
      "new_rows": 52,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "9dc62280e03d60b9b60c54407d8d5048ca703f4f9cb702f3938ac7d97d19aa09",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f5c8bedd1257bce3d40b895a576e3ae329d320655a88f2abde9296a7a9e60889",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 26,
      "new_rows": 26,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "10adfa9e70c6adbb4794fd72083708bbcfbd06372ce61b9634549a971c3259cf",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=26&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 26,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "b1c2da79a54760df102f0862688713eeec2f976749f274f87bd3e76598a6b5f4",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 26,
      "new_rows": 26,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "10adfa9e70c6adbb4794fd72083708bbcfbd06372ce61b9634549a971c3259cf",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Lipigon+Pharmaceuticals+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=26&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 26,
      "pagination": "row-offset",
      "query_text": "Lipigon Pharmaceuticals AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "b1c2da79a54760df102f0862688713eeec2f976749f274f87bd3e76598a6b5f4",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 15,
      "new_rows": 15,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "87f306c9eefc5e886d272e89295e3ec23c07aa293607ff8f54f4a9108a23a828",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=15&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "sv",
      "start": 15,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "11f6a638635089d9cd0aa6b3cd9b352af0e40b705e883c53c935beaa1b8bf549",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "5c5c98a008438a81656aa57cb05a062387ed36d4d1e5a789f5e1b29f68fda993",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 55,
      "new_rows": 55,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "863de1b44488c1260188782218ab95e0e1d4683fbad3f0ffa92fcd583ae1caef",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "58245a511213cc7a8b47ab223bd80f9f323d09814deef91ba62c08e875e7aa1c",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "sv",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 70,
      "new_rows": 70,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "3dd40920669ecf244ffbe5ab68dec5198fc86302811f77f26d80668d0c44fe4a",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 18,
      "new_rows": 18,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "b43d0f472768bf882b98e2eebae286e3bb3366c034b0d80bac19129f889299c0",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=18&dir=DESC",
      "status": 200,
      "scope": "NordicMainMarkets",
      "language": "en",
      "start": 18,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 0,
      "new_rows": 0,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "96b980cdd7a6bb29a9dc5559080ebd23ed4f23f15290283808f3318cce2c8c58",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "aa12a0d20a6c8ed45e626322a5c2a556b7f5d10b9def807d866be49234d356ad",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "NordicFirstNorth",
      "language": "en",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 1,
      "new_rows": 1,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "db13b06533bba3ca6eca9b5ce68cbf6b8fde0ff4395b85732d28b2ff2a4d75d4",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 0,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 100,
      "new_rows": 100,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "f3199cfc70c3b09625eb17c924ef5117f4049860e4c0bb8fcf257b0e6970d034",
      "recovery_target": "2024:q1"
    },
    {
      "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Karo+Pharma+AB&company=&market=&cnscategory=&fromDate=2024-03-01&toDate=2024-06-15&globalGroup=&globalName=&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC",
      "status": 200,
      "scope": "all-nordic",
      "language": "en",
      "start": 100,
      "pagination": "row-offset",
      "query_text": "Karo Pharma AB",
      "from_date": "2024-03-01",
      "to_date": "2024-06-15",
      "cache_tag": "recover-2024-q1",
      "rows": 19,
      "new_rows": 19,
      "total_count": null,
      "from_cache": false,
      "body_sha256": "9b69fa6a4b9134c9ae8f622069c80bfdcf7b31b33e54adfe6d53d2cd9dcf5e8d",
      "recovery_target": "2024:q1"
    }
  ],
  "identity": {
    "slug": "",
    "instrument_id": "TX5398996",
    "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/eql?id=TX5398996"
  },
  "transport": "ordinary-http",
  "browser_used": false,
  "query_text": "EQL Pharma",
  "retrieved_at": "2026-08-07T03:29:13Z"
}